Julia Salmerón-Villalobos

60PUBLICATIONS
249CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)GlycoconjugatesGene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Sep 08, 2026
The superior prognostic role of pRB1 over p16 immunohistochemistry as a biomarker in meningiomas.

|Aug 29, 2026
DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression.

|Jun 26, 2026
Integrated Multi-Omics Analysis Reveals an HCMV-Associated Late-Gene Signature Associated with Poor Survival in Pediatric Group 3 Medulloblastoma.

|Apr 20, 2026
Impact of granulation pattern on surgical and long-term outcomes in Cushing's disease: a comparative study of DGCT and SGCT.

|Mar 24, 2026
Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort.

David Rieger, Hannes Becker, Bianca Walter

|Mar 02, 2026
Voxel-based spatial distribution of intracranial meningioma subtypes and their relationship to radiogenomic maps.

Georgios Naros, Aldo Spolaore, Sophie Wang

Pageof 10

Frequent Collaborators

14 joint publications

Felix Behling

13 joint publications

Ghazaleh Tabatabai

11 joint publications

Felix Sahm

6 joint publications

Martin Ebinger